IQSM:NYE-Iq Candriam ESG U.S. Mid Cap Equity ETF (USD)

ETF | Others |

Last Closing

USD 29.2292

Change

+2.43 (+9.06)%

Market Cap

N/A

Volume

947.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-09 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
SOJE Southern Company (The) Series ..

+0.02 (+0.11%)

USD 65.72B
SGOV iShares® 0-3 Month Treasury B..

+0.04 (+0.04%)

USD 40.47B
JEPI JPMorgan Equity Premium Income..

+0.15 (+0.28%)

USD 36.19B
JPST JPMorgan Ultra-Short Income ET..

N/A

USD 31.44B
DFAC Dimensional U.S. Core Equity 2..

+0.13 (+0.42%)

USD 29.60B
DTB DTE Energy Company 2020 Series

+0.10 (+0.58%)

USD 26.58B
JAAA Janus Detroit Street Trust - J..

+0.06 (+0.12%)

USD 21.14B
GBTC Grayscale Bitcoin Trust (BTC)

+0.47 (+0.71%)

USD 16.17B
CGDV Capital Group Dividend Value E..

-0.12 (-0.36%)

USD 14.38B
AVUV Avantis® U.S. Small Cap Value..

+1.22 (+1.54%)

USD 13.13B

ETFs Containing IQSM

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.96% 22% F 30% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.96% 22% F 30% F
Trailing 12 Months  
Capital Gain -6.28% 23% F 35% F
Dividend Return 0.54% 10% F 8% B-
Total Return -5.74% 19% F 30% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 6.90% 75% C 59% D-
Dividend Return 7.32% 73% C 53% F
Total Return 0.42% 26% F 11% F
Risk Return Profile  
Volatility (Standard Deviation) 9.26% 54% F 80% B-
Risk Adjusted Return 79.07% 81% B- 86% B+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.